STOCK TITAN
  1. Home
  2. Sec-filings
  3. CORZ
  4. [Form 4] Core Scientific, Inc./tx Insider Trading Activity

Core Scientific (CORZ) legal chief sells 10,000 shares in 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Core Scientific, Inc. reported that Chief Legal and Administrative Officer Todd M. Duchene sold a total of 10,000 shares of common stock on August 3, 2026. The sales occurred in three open market or private transactions at weighted-average prices of $20.3903, $21.55 and $22.6166 per share. All trades were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, with individual sales taking place within price ranges of $19.99–$20.72, $21.03–$21.95 and $22.12–$22.95 per share.

Positive

  • None.

Negative

  • None.
Insider DUCHENE TODD M
Role See remarks
Sold 10,000 shs ($222K)
Type Security Shares Price Value
Sale Common Stock F1, F2 1,000 $20.3903 $20K
Sale Common Stock F1, F3 1,500 $21.55 $32K
Sale Common Stock F1, F4 7,500 $22.6166 $170K
Holdings After Transaction: Common Stock — 1,979,101 shares (Direct)
Footnotes (4)
  1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.99 to $20.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  4. F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.12 to $22.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Total shares sold 10,000 shares Aggregate Core Scientific common shares sold by Todd M. Duchene on August 3, 2026
Shares sold, tranche 1 1,000 shares Common stock sold on August 3, 2026 at a weighted-average price of $20.3903 per share
Price, tranche 1 $20.3903 per share Weighted-average sale price for 1,000 shares of common stock on August 3, 2026
Shares sold, tranche 2 1,500 shares Common stock sold on August 3, 2026 at a weighted-average price of $21.55 per share
Price, tranche 2 $21.55 per share Weighted-average sale price for 1,500 shares of common stock on August 3, 2026
Shares sold, tranche 3 7,500 shares Common stock sold on August 3, 2026 at a weighted-average price of $22.6166 per share
Price, tranche 3 $22.6166 per share Weighted-average sale price for 7,500 shares of common stock on August 3, 2026
Rule 10b5-1 trading plan financial
"transactions were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"transaction code "S" described as Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did CORZ disclose for Todd M. Duchene?
Core Scientific (CORZ) reported that Todd M. Duchene, its Chief Legal and Administrative Officer, sold 10,000 shares of common stock on August 3, 2026. The sale was executed in three open market or private transactions at weighted-average prices of $20.3903, $21.55 and $22.6166 per share.

Were the CORZ insider sales made under a Rule 10b5-1 trading plan?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted by Todd M. Duchene on December 5, 2025. This indicates the August 3, 2026 sales followed a pre-arranged schedule rather than discretionary, same-day trading decisions.

How many Core Scientific (CORZ) trades did Todd M. Duchene report?
Todd M. Duchene reported three separate transactions in Core Scientific common stock on August 3, 2026. Each transaction is coded “S” for sale and described as a sale in open market or private transaction, together totaling 10,000 shares sold under his Rule 10b5-1 plan.

At what prices were the CORZ shares sold by Todd M. Duchene?
The reported per-share prices are weighted averages of $20.3903, $21.55 and $22.6166 for the three tranches. Footnotes explain these averages reflect multiple trades within ranges of $19.99–$20.72, $21.03–$21.95 and $22.12–$22.95 per share, respectively.

What is Todd M. Duchene’s role at Core Scientific (CORZ)?
Todd M. Duchene is identified as Core Scientific’s Chief Legal and Administrative Officer. The Form 4 lists him as an officer of the company, with his specific title provided in the remarks section accompanying the insider transaction disclosure for the August 3, 2026 stock sales.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DUCHENE TODD M
(Last)(First)(Middle)
C/O CORE SCIENTIFIC, INC.
838 WALKER ROAD, SUITE 21-2105
(Street)
DOVER DELAWARE 19904
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/03/2026S(1)1,000D$20.3903(2)1,988,101D
Common Stock08/03/2026S(1)1,500D$21.55(3)1,986,601D
Common Stock08/03/2026S(1)7,500D$22.6166(4)1,979,101D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.99 to $20.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.12 to $22.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Remarks:
Chief Legal and Administrative Officer
/s/ Todd DuChene08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR